About Hema.to

Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data.

Company Highlights
Year Founded

2021

icon-altEmployees

25

Location (HQ)

DEU

Since Last Funding

1 year 3 months

Monthly Website Visitors

4.8K

icon-altTotal Investment Amt

$3.9M

Last Funding Round

Seed

icon-altMoM Headcount Growth

4.15%

icon-altYoY Headcount Growth

18.96%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Software Development

Health Diagnostics